Inhaled glucocorticoids in asthma

Joe K. Gerald

doi:10.1056/NEJMc1804801

Inhaled glucocorticoids in asthma

Joe K. Gerald

Community, Environment and Policy

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2049-2050
Number of pages	2
Journal	New England Journal of Medicine
Volume	378
Issue number	21
DOIs	https://doi.org/10.1056/NEJMc1804801
State	Published - May 24 2018

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc1804801

Cite this

@article{4c3ca2c7666c4de693b98bc97a45b561,

title = "Inhaled glucocorticoids in asthma",

author = "Gerald, {Joe K.}",

note = "Funding Information: Dr. Morjaria reports having received honoraria for speaking and financial support to attend meetings and serve on advisory boards from Wyeth, Chiesi, Pfizer, MSD, Boehringer Ingelheim, Teva Pharmaceutical Industries, GlaxoSmithKline–Allen and Hanburys, Napp, Almirall, AstraZeneca, Trudell Medical International, and Novartis. No other potential conflict of interest relevant to this letter was reported. Funding Information: Supported by a grant-in-aid for scientific research (KAKENHI 15K08815) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.",

year = "2018",

month = may,

day = "24",

doi = "10.1056/NEJMc1804801",

language = "English (US)",

volume = "378",

pages = "2049--2050",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "21",

}

TY - JOUR

T1 - Inhaled glucocorticoids in asthma

AU - Gerald, Joe K.

N1 - Funding Information: Dr. Morjaria reports having received honoraria for speaking and financial support to attend meetings and serve on advisory boards from Wyeth, Chiesi, Pfizer, MSD, Boehringer Ingelheim, Teva Pharmaceutical Industries, GlaxoSmithKline–Allen and Hanburys, Napp, Almirall, AstraZeneca, Trudell Medical International, and Novartis. No other potential conflict of interest relevant to this letter was reported. Funding Information: Supported by a grant-in-aid for scientific research (KAKENHI 15K08815) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.

PY - 2018/5/24

Y1 - 2018/5/24

UR - http://www.scopus.com/inward/record.url?scp=85047348481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047348481&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1804801

DO - 10.1056/NEJMc1804801

M3 - Letter

C2 - 29792405

AN - SCOPUS:85047348481

VL - 378

SP - 2049

EP - 2050

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -

Inhaled glucocorticoids in asthma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this